Bioptimus will connect the different scales of biology with generative AI; from molecules to cells, tissues and whole organisms, to fuel scientific breakthroughs and accelerate innovation in biomedicine and beyond
French startup Bioptimus emerged from stealth following a seed funding round of $35M. Under the leadership of Professor Jean-Philippe Vert, PhD, Bioptimus...
AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the US for the treatment of adult patients with locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) who have received prior systemic therapy. The Prescription Drug User Fee Act date, the...
Advances include faster and more robust protein structure prediction; higher-quality models of protein/protein interactions; large-scale screening and improved de novo protein design for therapeutics
OpenFold, a non-profit artificial intelligence (AI) research consortium, announced the release of two new tools: 1) SoloSeq, which integrates a new protein Large Language Model (LLM)...
InveniAI® LLC, a global leader in the application of artificial intelligence (AI) and machine learning (ML) tools to revolutionize drug discovery and development, announces a strategic collaboration with Ono Pharmaceutical Co., Ltd. (Ono), a renowned pharmaceutical company committed to advancing innovative solutions for unmet medical needs.
InveniAI's cutting-edge technology, including powerful...
Sequoia Biotech Consulting (Sequoia), a leading life sciences consulting firm renowned for its expertise in scaling life science organizations to deliver high-quality therapeutics, diagnostics, and medical devices, proudly announces the appointment of Kimberly Bennett as Chief Operating Officer (COO).
Having served as an invaluable member of Sequoia's executive leadership team for over...
-- Transformational degrader antibody conjugate company backed by leading syndicate including founding investor Versant Ventures, MPM BioImpact, Decheng Capital and Eli Lilly & Company --
Firefly Bio emerged from stealth mode with a $94 million Series A financing co-led by founding investor Versant Ventures and by MPM BioImpact alongside Decheng...
T-Mode TM AI by Clarius creates a split screen during an exam that displays a colorful anatomical image with labels next to the grayscale ultrasound image
Clarius Mobile Health, a global leader in wireless ultrasound solutions, announces T-ModeTM AI, a groundbreaking educational technology to help clinicians who are new to ultrasound advance their image...
Collaboration to leverage VantAI's expertise in generative AI and geometric deep learning to identify molecular glues against targets of interest with an option to expand to additional programs
VantAI, a company focused on generative AI-enabled drug discovery, and Bristol Myers Squibb, a leading pharmaceutical company, have entered into a strategic...
Roche announced that it has entered into an agreement with PathAI, a global leader in artificial intelligence (AI)-powered technology for pathology.
Under the terms of this agreement, PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop AI-enabled digital pathology algorithms in the companion diagnostics space. RTD will work...
Enable Medicine, a leader in AI for biological research and drug discovery, has announced the appointment of Kamni Vijay as Chief Executive Officer. She succeeds co-founder Sunil Bodapati, who developed Enable Medicine’s strategy and closed Series A financing in 2022. Mr. Bodapati remains Chairman of the Board and will...
